NASDAQ:INSM
INSMED Inc
INSMED Inc's revenue grew 66.7% in fiscal 2025 to $606.4M while operating margin rose to −205.6%. Free cash flow was −$967.6M, −159.6% of revenue, and the diluted share count rose 21.3%.Summary generated from INSMED Inc's SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$606.4M
Revenue growth+66.7%
Revenue, 5-yr CAGR+29.8%
Gross margin79.7%
Operating margin−205.6%
Net margin−210.5%
ROIC−121.0%
Return on equity−249.3%
Debt / equity0.74
Free cash flow−$967.6M
FCF margin−159.6%
Share count change+21.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 188 | 245 | 305 | 364 | 606 |
| Operating income | −375 | −457 | −710 | −878 | −1,247 |
| Net income | −435 | −482 | −750 | −914 | −1,277 |
| Free cash flow | −371 | −410 | −550 | −706 | −968 |
Recent filings
- 8-KDirector or officer change
Oct 5, 2026 - 4Insider transaction report
Sep 11, 2026 - 4Insider transaction report
Aug 19, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KRegulation FD disclosure
Jul 16, 2026 - 8-KResults of a shareholder vote
May 15, 2026 - 8-KResults of operations and financial condition
May 7, 2026